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Introduction
The contractile cortex is a 50-nm–2-μm-thick layer of cytoskel-
eton under the plasma membrane that is rich in actin fi  laments, 
myosin II, and actin-binding proteins (Bray and White, 1988). 
Assembly dynamics and contractility of this layer are thought to 
generate cortical tension, drive cytokinesis, and play a central 
role in cell locomotion and tissue morphogenesis (Bray and 
White, 1988; Alberts et al., 2004). Despite its importance, the 
structural organization, dynamics, membrane connections, and 
assembly pathway of contractile cortex are not well understood. 
The classic unit of contractile actomyosin organization is the 
sarcomere, a structure that is well characterized in muscle cells 
and present in stress fi  bers of nonmuscle cells (Cramer et al., 
1997; Alberts et al., 2004). However, typical contractile cortex 
does not contain well-organized sarcomeres by light or electron 
microscopy, and how its actin and myosin fi  laments are struc-
turally organized is unclear.
Understanding the structure and dynamics of the cortex is 
important because it determines how cells respond to mechanical 
force or generate force for shape change and movement. Cells are 
composite materials, with each constituent conferring different 
mechanical properties. The membrane bilayer enables the main-
tenance of a specifi  c microenvironment, but cannot expand or 
  retain a stable shape when subjected to environmental forces 
(Hamill and Martinac, 2001). The plasma membrane of red blood 
cells is stiffened by a submembranous cytoskeleton consisting of 
a meshwork of spectrin tetramers tethered both to plasma mem-
brane proteins and to short actin fi  laments by linking proteins, 
notably ankyrin and protein 4.1 (Bennett and Baines, 2001). Motile 
cells contain all of these proteins, but the extent and function of a 
submembranous cytoskeleton is unclear. They also have a much 
thicker and stiffer cortex under the plasma membrane, consisting 
of a shell of cross-linked actin fi  laments oriented tangential to the 
cell surface, which enables cells to better resist mechanical 
deformation (Bray and White, 1988). This shell can produce force 
either through myosin II–driven contraction or actin polymeriza-
tion. Myosin-driven contraction generates cortical tension that 
can be converted into different types of motility by appropriate 
symmetry breaking (Bray and White, 1988).
Biochemically, the proteinaceous composition of the cor-
tex is dominated by actin, actin-bundling proteins, and myosin II. 
How cortex is regulated and attached to the plasma mem-
brane is unclear. The small GTPase RhoA is probably the most 
important regulator of contractile cortex assembly (Etienne-
Manneville and Hall, 2002). Its activation leads to both actin 
polymerization and myosin II recruitment through several path-
ways in cytokinesis and chemotaxis (Lee et al., 2004; Bement 
et al., 2005; Kamijo et al., 2006), but its role in the regulation 
of generic contractile actin cortex is less well understood. 
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ontractile actin cortex is involved in cell morpho-
genesis, movement, and cytokinesis, but its orga-
nization and assembly are poorly understood. 
During blebbing, the membrane detaches from the cortex 
and inﬂ  ates. As expansion ceases, contractile cortex reas-
sembles under the membrane and drives bleb retraction. 
This cycle enabled us to measure the temporal sequence 
of protein recruitment to the membrane during cortex 
  reassembly and to explore dependency relationships. 
  Expanding blebs were devoid of actin, but proteins of the 
erythrocytic submembranous cytoskeleton were present. 
When expansion ceased, ezrin was recruited to the mem-
brane ﬁ   rst, followed by actin, actin-bundling proteins, 
and, ﬁ   nally, contractile proteins. Complete assembly of 
the contractile cortex, which was organized into a cage-
like mesh of ﬁ  laments, took  30 s. Cytochalasin D blocked 
recruitment of actin and α-actinin, but had no effect on 
membrane association of ankyrin B and ezrin. Ezrin 
played no role in actin nucleation, but was essential for 
tethering the membrane to the cortex. The Rho pathway 
was important for cortex assembly in blebs.
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RhoA directly activates formins, which are actin-nucleating pro-
teins that hold onto growing barbed ends (Higashida et al., 2004), 
and activates myosin II by regulation of its phosphorylation 
state through Rho-kinase (Totsukawa et al., 2000). The nature 
of the attachment of cortical actin to the membrane is poorly 
understood, despite identifi  cation of several protein candidates. 
In red blood cells, protein 4.1 links short actin fi  laments to inte-
gral membrane proteins, but its role in motile cells is less clear 
(Bennett and Baines, 2001). ERM (ezrin-radixin-moesin) pro-
teins are natural candidates because they can bind both actin 
and integral membrane proteins (Bretscher et al., 2002). ERM 
proteins switch from an inactive closed conformation to an ac-
tive open conformation that exposes an actin-binding site (at the 
tail) and a four one-ezrin-radixin-moesin (FERM) membrane–
targeting domain (at the head; Bretscher et al., 2002). Perturbation 
experiments in cells are consistent with ERMs functioning in 
actin-membrane linkage (Gautreau et al., 2000).
One challenge in dissecting assembly of the contractile 
cortex in cells has been fi  nding a starting point. The plasma 
membrane is almost always underlain by a cortex, and in situa-
tions like the assembly of the cytokinetic furrow, it is diffi  cult to 
evaluate the relative contributions of de novo assembly at the 
furrow site versus sliding of cortical elements from neighboring 
membrane. One natural situation where cortex-free membrane 
is transiently generated is blebbing. This is a dramatic type of 
cell motility involving the contractile cortex that is often ob-
served during apoptosis (Mills et al., 1998) and cytokinesis 
(Fishkind et al., 1991) and takes part in migration of some em-
bryonic cells (Trinkaus, 1973). Bleb nucleation is initiated by 
the rapid detachment of a patch of membrane from the cortex. 
The patch is infl  ated over  30 s to form a spherical protrusion 
that is 1–10 μm in diameter and fi  lled with cytosol  (Cunningham, 
1995). When expansion stops, contractile cortex reassembles 
under the bleb membrane, and the bleb is retracted. Retraction 
fi  nishes as the bleb cortex reintegrates the bulk cell cortex. 
Membrane detachment and bleb infl  ation are thought to be 
driven by intracellular pressure transients generated by myosin II 
contraction of the actin cortex. Indeed, drugs that relax the 
  cortex by inhibiting actin or myosin II inhibit blebbing. We take 
advantage of blebbing as a window into the process of cortical 
assembly and dissect its assembly pathway.
Results
Bleb dynamics as a system to explore 
cortex assembly
Bleb expansion occurs when the membrane detaches from the 
actin cortical cytoskeleton. Imaging of constitutively blebbing 
Figure 1.  Localization of proteins during bleb 
expansion and retraction. All images were ac-
quired using confocal microscopy. Timing rela-
tive to the ﬁ  rst image is indicated in white text. 
(A) Localization of the membrane marker (the 
PH domain of PLCδ, red) and actin (green) dur-
ing bleb expansion and retraction. The actin 
cortex is intact during bleb expansion (arrows) 
and is disassembled at later time points. (B–D) 
Ankyrin B (B), protein 4.1 (C), and myosin I 
(myr3, D) localize to the cell membrane 
throughout the life of a bleb. (E) Spectrin (green) 
colocalizes with actin (red) in retracting blebs. 
Bars, 1 μm.CORTEX ASSEMBLY IN BLEBS • CHARRAS ET AL. 479
M2 cells expressing both GFP-actin and a membrane marker, the 
PH domain of phospholipase C δ (PH-PLCδ), tagged with mono-
meric red fl  uorescent protein (mRFP) confi  rmed the absence of 
large amounts of actin in growing blebs and the persistence of an 
actin cortex in the cell body beneath the growing bleb (Fig. 1 A). 
Abundant cortical actin remains at the site of membrane detach-
ment in the cell body during bleb expansion (Fig. 1 A, arrows). 
Actin is progressively recruited to the membrane during retraction 
(Fig. 1 A and Fig. 5, A–C). Thus, bleb dynamics provide a system 
to distinguish cortical proteins that associate constitutively with 
the plasma membrane from those that associate only when an 
 actin cortex is present or assembling. We investigated the dynamics 
of 24 different cortical proteins in this system (Table I), selecting 
candidate proteins implicated in cortex–membrane attachment, 
actin organization, and contractility. 
Proteins present during bleb expansion
Ankyrin B (Fig. 1 B) and protein 4.1 (nonerythroid isoform; 
Fig. 1 C), which are proteins of the erythrocyte cytoskeleton, 
formed a distinct rim of fl  uorescence at the bleb membrane, 
with no difference in intensity between expanding and con-
tracting blebs. Myr 2 and 3, which are myosin I isoforms that 
target to the membrane (Barylko et al., 2000), exhibited simi-
lar dynamics (Fig. 1 D and not depicted). Thus, these proteins 
are constituents of a protein network that underlies the mem-
brane at all times during bleb dynamics. We were unable to 
express full-length GFP-spectrin or GFP-adducin, but immuno-
staining revealed a distinct rim of spectrin (Fig. 1 E) and 
adducin (Fig. S1 B, available at http://www.jcb.org/cgi/
content/full/jcb.200602085/DC1) at the bleb cortex in fi  xed 
cells.   Because contracting blebs are better preserved than 
  expanding blebs during fi   xation, these images most likely 
  reveal association during or after actin assembly. We have no 
data on spectrin or adducin in expanding blebs, but suspect 
they must be present because proteins that associate with them 
(ankyrin B and protein 4.1) are present. In summary, a sub-
membranous cytoskeleton is present at all times during the 
blebbing cycle, and the cytoskeleton of cortex-free expanding 
Table I. Protein composition of the principal cellular actin structures
Protein Technique Bleb Lamellipodium Cytokinetic ring Filopodia/microvilli Phagocytotic cup
Ezrin Immunostaining, GFP-tagging Yes, between actin 
and membrane
Yes (Denker and 
Barber, 2002)
Yes (Bretscher, 1991) Yes (Defacque et al., 
2000)
Moesin GFP-tagging Yes Yes (Defacque et al., 
2000)
α-actinin Immunostaining, GFP-tagging Yes, colocalized 
with actin
Yes, mesh (Small et al., 2002) Yes (Satterwhite and 
Pollard, 1992; Wu 
et al., 2003)
Yes (Bretscher, 1991) Yes (May and 
Machesky, 2001)
Fimbrin Immunostaining, GFP-tagging Yes, colocalized 
with actin
Yes, mesh (Small et al., 2002) Yes (Small et al., 2002)
Fascin GFP-tagging
Immunostaining
No Yes, mesh (Small et al., 2002) Yes (Small et al., 2002)
Filamin Immunostaining Yes (HeLa cells) Yes, mesh (Stossel et al., 2001; 
Small et al., 2002)
Yes (Small et al., 2002) Yes (May and 
Machesky, 2001; 
Stossel et al., 2001)
Anillin Immunostaining, GFP-tagging Yes Yes (Straight et al., 
2005; Wu et al., 
2003)
Coronin GFP-tagging Yes Yes, mesh (Small et al., 2002) Yes (Wu et al., 2003) Yes (Rybakin and 
Clemen, 2005)
Septin Immunostaining, GFP-tagging No Yes (Sanders and 
Field, 1994; Wu 
et al., 2003; Spiliotis 
et al., 2005)
Tropomyosin GFP-tagging, Immunostaining Yes, colocalized 
with actin
Yes (Wu et al., 2003) Yes (Bretscher, 1991)
Tropomodulin GFP-tagging Yes
Myosin II Immunostaining, GFP-tagging Yes, below the 
actin cortex
Yes, mesh Yes (Satterwhite and 
Pollard, 1992; Wu 
et al., 2003)
Myosin I GFP-tagging Yes Yes (Bretscher, 1991)
mDia1 GFP-tagging No Yes (Wu et al., 2003) 
Arp2/3 GFP-tagging,
Immunostaining
No Yes, leading edge and mesh 
(Small et al., 2002)
Yes (Castellano et al., 
2001)
VASP GFP-tagging, Immunostaining No Yes, leading edge (Small 
et al., 2002)
Yes (Small et al., 2002) Yes (Castellano et al., 
2001)
Adducin Immunostaining Yes
Annexin II GFP-tagging No
Capping protein GFP-tagging No Yes (Small et al., 2002) Yes (Wu et al., 2003)JCB • VOLUME 175 • NUMBER 3 • 2006  480
blebs may resemble the rudimentary cytoskeleton that underlies 
the erythrocytic membrane.
ERM proteins are recruited early during 
bleb retraction
The transition from bleb expansion to stasis and, fi  nally, con-
traction occurs over  30 s. This transition involves the recruit-
ment of a new cortex to the membrane and provides a time 
window for measuring the relative timing of recruitment of cor-
tical components, and testing dependency relationships. We im-
aged the recruitment dynamics of 18 different actin associated 
proteins. Eight did not localize to the bleb rim, and 10 tran-
siently associated with the bleb rim (Table I and Figs. 2–4). We 
investigated the relative timing of the appearance of actin and 
six representative proteins that belonged to the three main 
classes of actin-binding proteins (linker proteins, bundling pro-
teins, and proteins of the contractile apparatus) by measuring 
when the protein was fi  rst detectable above background at the 
Figure 2.  Localization of ERM proteins during 
bleb expansion and retraction. All images 
were acquired using confocal microscopy. Tim-
ing relative to the ﬁ   rst image is indicated in 
white letters. (A) Ezrin (green) is initially absent 
from the membrane of expanding blebs. Once 
expansion stops, ezrin is recruited to the bleb 
and forms a continuous rim colocalized with 
the membrane. The bleb membrane (red) is 
visualized using the PH domain of PLCδ. (B) 
Ezrin (green) appears before actin (at 20 vs. 
30 s) and forms a continuous rim external to 
the actin shell (red, inset). (C) Moesin is absent 
from the membrane of expanding blebs, but 
later forms a continuous rim. Bars, 2 μm.
Figure 3.  Localization of proteins relative to 
the membrane during bleb retraction. All im-
ages were acquired using confocal micros-
copy. The PH domain of PLCδ, a membrane 
marker, is visualized in red and the protein of 
interest in green. Timing relative to the ﬁ  rst im-
age is indicated in white text. MRLC (A) local-
izes to distinct foci (arrows and inset) under the 
bleb membrane in retracting blebs. α-Actinin 
(B), tropomyosin (C), and anillin (D) all form a 
continuous rim under the bleb membrane once 
expansion has stopped. Bars, 2 μm.CORTEX ASSEMBLY IN BLEBS • CHARRAS ET AL. 481
bleb rim, and then normalized this time to the time when actin 
recruitment was fi  rst detected at the rim (Fig. 5 D). 
The fi  rst protein recruited was ezrin (Fig. 2, A and B), 
which links the actin cytoskeleton to the membrane. Ezrin was 
not enriched at the membrane during expansion, but rapidly 
  localized to the bleb membrane as expansion slowed, forming a 
continuous rim colocalized with the membrane (Fig. 2 A). In 
two color videos, the actin rim was displaced toward the   center 
of the bleb compared with the ezrin rim (Fig. 2 B, inset [t = 42 s], 
and Fig. S1 D), which is consistent with ezrin’s role as a 
  membrane linker (Bretscher et al., 2002). Recruitment of ezrin 
preceded recruitment of actin by 4.87 ± 3 s (Pactin < 0.01; 
n = 23; Fig. 2 B and Fig. 5 D). The delay between actin and 
  ezrin recruitment could be visualized on two color   kymographs 
(Fig. 5 A), where the newest cortex appears greener (ezrin rich/
actin poor) compared with the older cortex (yellow). Moesin, 
another ERM family protein, had a localization similar to 
ezrin (Fig. 2 C).
Staged recruitment of other 
cortical proteins
Three actin-binding proteins were recruited shortly, but signifi  -
cantly, after actin itself. These were α-actinin (2.4 ± 4 s relative 
to actin, n = 20, Pactin < 0.01; Fig. 3 B, Fig. 5 B, and Fig. S1 A), 
coronin (1.5 ± 1.5 s relative to actin, n = 23, Pactin < 0.01; Fig. 
4 B), and tropomyosin-4 (1.3 ± 1.5 s relative to actin, n = 19, 
Pactin < 0.01; Fig. 3 C and Fig. S1 H). All formed a uniform 
shell, exactly colocalized with actin, and presumably coassem-
bled with new actin polymer. The timing of arrival of these pro-
teins was not signifi  cantly different from one another (pairwise 
comparisons, P > 0.29). Fimbrin also assembled in a  continuous 
rim colocalized with actin at the bleb periphery, but signifi  -
cantly later than the previous three (8.17 ± 4.9 s relative to 
 actin,  n = 17; Fig. 4 C and Fig. S1 E).
Myosin II recruitment to the bleb cortex is thought to 
drive bleb retraction. Myosin regulatory light chain (MRLC) 
was recruited signifi  cantly later than the early actin-binding 
proteins (7.3 ± 2.4 s relative to actin, n = 27, P < 0.01 for each 
pair-wise comparison with the early actin-binding proteins; Fig. 
3 A, Fig. 4 A, and Fig. 5, C and D). Unlike other actin-binding 
proteins, MRLC and myosin heavy chain (MHC) assembled 
into small puncta that may represent contractile foci (Fig. 3 A, 
Fig. 4 A, Fig. S1 F, and not depicted).
Anillin (Fig. 3 D and Fig. S1 C) and tropomodulin (not 
depicted), proteins that regulate or interact with myosin II and 
actin (Fowler et al., 2003; Straight et al., 2005), were recruited 
to retracting blebs as a continuous rim, suggesting that they 
bind primarily to actin rather than myosin II.
Other proteins tested (i.e., VASP, Arp3, mDia1, fascin, 
capping protein, sept6, annexin II, tubulin, and vimentin) were 
not enriched in blebs by immunostaining or expression of full- 
length GFP-tagged constructs (unpublished data).
Cortical ultrastructure in retracting blebs
Three different electron microscopy techniques were used 
to probe bleb ultrastructure. Scanning electron microscopy 
(SEM) examination of blebbing cells fi  xed without permea-
bilization (Fig. 6 A) confi  rmed that fully extended blebs were 
approximately spherical and that retracting blebs displayed 
a crumpled morphology (Fig. 6 A, inset). Live observation 
Figure 4.  Localization of proteins relative to actin during bleb retraction. All images were acquired using confocal microscopy. In all images, actin is in 
red and the protein of interest in green. Timing relative to the ﬁ  rst image is indicated in white text. (A) MRLC is originally not present (0–15 s) in the bleb, 
but assembles in distinct foci underneath the actin shell. (B) Coronin appears shortly after actin and forms a continuous rim colocalized with the actin shell. 
(C) Fimbrin appears after actin (44 vs. 18 s) and forms a continuous rim colocalized with the actin shell. Bars, 2 μm.JCB • VOLUME 175 • NUMBER 3 • 2006  482
of cells during triton permeabilization, with or without simul-
taneous aldehyde fi  xation, showed that only retracting blebs 
survive permeabilization (unpublished data). Thin-section trans-
mission electron microscopy (TEM) of saponin-permeabilized 
aldehyde-fi  xed cells revealed that the cortex of retracting blebs 
comprises a 10–20-nm-thick shell of actin fi  laments (verifi  ed 
by immunoTEM; not depicted) and shows clear signs of crum-
pling (Fig. 6 B). The best views of actin organization were 
provided by SEM examination of cells permeabilized in the 
presence of phalloidin to stabilize fi  lamentous actin. Actin in 
retracting blebs formed an interconnected network resembling 
a cage (Fig. 6, C and D). Incubation of extracted cells with the 
S1 fragment of myosin revealed that all of the fi  bers within 
the cagelike structures were actin fi  laments (Fig. 6 D). Distinct 
knots were apparent at the vertices, but actin fi  laments’ polari-
ties showed no specifi  c order around these (Fig. 6 D, arrow). 
Typical distances between adjacent vertices were 200 nm, or 
 80 actin subunits, but this varied considerably between blebs, 
perhaps refl  ecting the age of the cortex, the degree of cross-
linking, or how advanced contraction was. To test the general-
ity of this organization, we examined blebs that occur naturally 
during cytokinesis in HeLa cells. Actin ultrastructure in HeLa 
blebs was identical, except that the actin mesh was tighter 
(Fig. 6 E). Interestingly, the cortex of HeLa cells   arrested in 
metaphase had a similar morphology, but with a much tighter 
mesh ( 20 nm; Fig. 6 F) and a thicker shell (50–100 nm; 
not depicted).
Actin dependence of protein recruitment
Timing alone can only suggest an assembly hierarchy, testing 
it requires perturbation experiments to reveal dependency rela-
tionships. The fast dynamics of the bleb cycle calls for fast per-
turbations, such as addition of cell-permeable drugs, but these 
are only available for a limited number of targets.
Treatment of blebbing cells with cytochalasin D, a drug 
that blocks actin polymerization at the barbed end, had two 
effects. At short times ( 30 s), bleb initiation and expansion 
was stimulated; at longer times, blebbing was inhibited. This 
dual effect may arise because initially, the attachment between 
actin and the membrane is destabilized by cytochalasin D treat-
ment, promoting bleb nucleation. At longer times, contraction 
of the cortex was compromised and new blebs ceased to  appear. 
Blebs that had already formed an actin cortex before the onset 
of treatment were not affected and retracted normally (Fig. 7 A, 
white arrows). Conversely, blebs that emerged shortly   after 
treatment did not assemble an actin rim and did not retract 
(Fig. 7 A, red arrows). This last effect allowed us to determine 
which proteins depend on actin for their recruitment to the 
bleb membrane.
To test the actin dependence of cortical protein recruit-
ment, we imaged M2 cells transfected with GFP-tagged ankyrin B, 
ezrin, α-actinin, or coronin during cytochalasin D treatment. 
Cytochalasin D treatment did not affect either the localization 
or level of ankyrin B at the bleb membrane (Fig. 7 C). This 
was expected, given its constitutive targeting to the membrane. 
Figure 5.  Timing of arrival of actin binding pro-
teins in the bleb relative to actin. (A–C) Kymo-
graphs showing the localization of actin (red) 
compared with actin-binding proteins (green) 
during bleb retraction. Bleb extension is shown 
on the horizontal axis and time is shown on the 
vertical axis. Ezrin (A, green) arrives in the bleb 
signiﬁ  cantly before actin and, consequently, a 
green trace can be seen at the bleb rim. As ac-
tin gets recruited to the rim, the trace turns yel-
low because of colocalization with ezrin. 
α-Actinin (B, green) and MRLC (C, green) are 
recruited after actin (red) and, consequently, a 
red trace can be seen ﬁ  rst at the bleb rim. This 
trace turns yellow as these proteins are re-
cruited to the rim. (D) Timing of arrival of the 
different actin-binding proteins in relationship 
to actin (t = 0 s). The error bars represent SD. 
Asterisks denote signiﬁ  cant differences in tim-
ing. Ezrin arrives at the bleb rim signiﬁ  cantly 
before actin. Coronin, α-actinin, and tropo-
myosin arrive signiﬁ  cantly later than actin. Finally, 
ﬁ  mbrin and myosin II appear last.CORTEX ASSEMBLY IN BLEBS • CHARRAS ET AL. 483
α-Actinin was not recruited to the rim of blebs that emerged 
  after the beginning of drug treatment and remained cytoplasmic 
(Fig. 7 B), which is consistent with coassembly of α-actinin and 
F-actin. Ezrin was still recruited to the membranes of blebs 
that formed after treatment (Fig. 7 E), and accumulated pro-
gressively at these membranes, giving a signal identical to that 
seen during the normal bleb cycle (cytochalasin, 76 ± 36%, 
n = 20 vs. control, 66 ± 31%, n = 23, P = 0.34). Thus, ezrin 
can target to membranes independent of actin and its localiza-
tion, and   kinetics are similar with and without actin. Coronin-3 
was also recruited to blebs that formed after onset of treatment 
(unpublished data).
ERM proteins mediate cell–membrane 
attachment, but do not nucleate actin
The kinetics of ezrin recruitment, its response to cytochalasin D, 
and reports of ERM-mediated actin nucleation (Defacque et al., 
2000), suggested an important role for this protein in cortex 
  reassembly. To assess the role of ezrin in actin nucleation, 
we incubated cells expressing mRFP-actin and GFP-ezrin with 
drugs targeting reported regulators of ezrin (Lee et al., 2004). 
The only drug to have an effect on ezrin recruitment to the cell 
membrane was the broad-specifi  city kinase inhibitor staurosporine. 
Blebs that formed after staurosporine addition did not recruit 
ezrin to the bleb membrane, did form an actin rim, and did not 
retract (Fig. 7 D). Hence, ezrin localizes to the bleb rim earlier 
than actin but does not nucleate   actin. Lack of retraction is 
  presumably caused by inhibition of kinases that phosphorylate 
myosin. In blebs formed before staurosporine addition, ezrin 
fl  uorescence at the rim gradually decreased until it was no lon-
ger detectable above background. Drugs that targeted Rho-
  kinase (Y27632), protein kinase A (H89, K252C, and HA1077), 
protein kinase C (Go6976, K252C, and H9), tyrosine kinases 
(Genistein), G proteins (pertussis toxin and suramin), or phos-
photidylinositol bisphosphate (PIP2; PBP-10; Cunningham 
et al., 2001) had no effect on ezrin localization to the bleb rim 
(unpublished data).
To further investigate the role of ezrin in bleb retraction, 
we perturbed ezrin function by overexpressing or microinjecting 
mutant forms of ezrin into cells expressing actin-GFP. Micro-
injection of recombinant FERM domain of ezrin-mRFP caused 
acute defects in bleb retraction. Actin was still recruited to the 
rim of blebs, but as retraction initiated the actin rim tended to tear 
away from the membrane, resulting in an inward fl  ow of   actin 
but complete or partial failure of membrane retraction (Fig. 8 A 
and Table II). Conversely, when recombinant ezrin-T567D-GFP 
was microinjected into blebbing cells, it localized to the sub-
membranous cortex and inhibited blebbing, suggesting stabili-
zation of actin–membrane links (Fig. 8 B and Table II). Stable 
expression of mutant forms of ezrin had effects consistent with 
Figure 6.  Actin ultrastructure in retracting blebs. (A) SEM 
of a blebbing cell with an intact cell membrane. (inset) As 
the retraction ends, the bleb membrane is crumpled. (B) 
TEM of the actin cortex of a retracting bleb. The bleb inte-
rior is devoid of cytoskeletal structures. Actin is concen-
trated at the bleb rim and forms a thin shell that is 10–20 nm 
thick. (C) Actin cytoskeleton of a blebbing cell. (D) Enlarge-
ment of boxed area in C. The cortex is formed by an en-
tangled meshwork of actin with a few protuberant knots 
(arrow). The mesh size is  200 nm. Myosin S1 head dec-
oration shows no speciﬁ  c orientation of the actin around 
the knots. (E) Actin cytoskeleton of a bleb in a dividing 
HeLa cell. The morphology of blebs is similar to that of 
  ﬁ  lamin-deﬁ  cient cells, but the mesh is ﬁ  ner. (F) Actin cortex of 
a rounded HeLa cell. The morphology of the cortex is simi-
lar to that of blebs. The entire cell is shown in the inset.JCB • VOLUME 175 • NUMBER 3 • 2006  484
membrane–actin attachment, depending on ezrin function. M2 
cells bleb profusely after plating, and the proportion of bleb-
bing cells decreases over a period of days (Cunningham, 1995). 
Cells expressing dominant   active ezrin-T567D-GFP stopped 
blebbing earlier than wild-type cells; whereas cells expressing 
either the FERM domain of ezrin-GFP or dominant-negative 
ezrin-T567A-GFP blebbed in higher proportion than wild-type 
cells (Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200602085/DC1; Gautreau et al., 2000).
These data lead us to propose that ezrin serves to mechan-
ically tether the plasma membrane to the forming actin cortex 
but does not participate in actin nucleation.
Myosin II powers bleb retraction
Studying the signaling events leading to bleb retraction is chal-
lenging because drugs that might inhibit retraction also inhibit 
general contractility of the actin cortex, making the effects on 
retraction alone diffi  cult to interpret. To unambiguously  examine 
Figure 7.  Localization of actin and actin-
binding proteins during bleb expansion and 
retraction in the presence of drugs. Cytochala-
sin D, an actin depolymerizer, was added at 
time t = 0 s. All images were acquired using 
confocal microscopy. The timing of each im-
age is indicated in white text. In all images, 
white arrows indicate blebs that have formed 
before the addition of cytochalasin D and red 
arrows indicate blebs that emerge after cyto-
chalasin D treatment. (A and B) Actin (A) and 
α-actinin (B) localize to the rim of blebs that 
have formed before treatment and which con-
tinue to retract. Blebs that form after treatment 
do not retract and the proteins stay cytoplas-
mic. (C) Ezrin localizes to the rim of blebs that 
have formed before treatment, as well as to the 
rim of those formed after treatment. (D) In the 
absence of staurosporine, ezrin localizes to 
the bleb rim (white arrow, t = −10 s). Blebs 
that form after the addition of staurosporine 
(t = 0 s), do not recruit ezrin to their rim, but do 
still form an actin rim (red arrows). Treatment 
with staurosporine causes the relocalization of 
extant ezrin from the bleb rim to the cytoplasm 
(white arrows). Bars, 5 μm.
Figure 8.  Mutant forms of ezrin modulate the attach-
ment of the cell membrane to the actin cytoskeleton. All 
images were acquired using wide-ﬁ  eld microscopy. Timing 
relative to the ﬁ  rst image is indicated in white letters. 
(A) Microinjection of the FERM domain of ezrin tagged 
with mRFP into cells expressing actin-GFP fragilizes the 
attachment of the membrane to the actin cortex. In re-
tracting blebs, the actin rim tended to tear away from the 
membrane (arrows at times t = 10 s and t = 30 s). This 
resulted in inwards ﬂ  ow of the actin rim, but the mem-
brane failed to retract. (B) Microinjection of constitutively 
active ezrin (ezrin T567D) tagged with GFP into actin-
mRFP–expressing cells causes the cessation of blebbing. 
Ezrin T567D colocalizes with actin at the cell periphery. 
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regulation of retraction, we decoupled bleb retraction from ex-
pansion using a brief application (<2 min) of cytochalasin D, 
followed by washing out. This creates a population of stationary 
blebs devoid of actin that retract upon washout by recruiting ac-
tin and MRLC (Fig. 9 A). The steps leading to actin nucleation 
and retraction can be investigated by inclusion of inhibitors in 
the washout medium.
Inclusion of the myosin II ATPase inhibitor blebbistatin in 
the washout medium had no effect on actin rim formation, but 
inhibited retraction (Fig. 9 B). Upon inactivation of blebbistatin 
by exposure to blue light (Sakamoto et al., 2005), retraction 
  resumed rapidly. In cells transfected with MRLC– tandem dimer 
RFP (TDRFP), blebbistatin did not inhibit recruitment of MRLC 
to the bleb rim (Fig. 9 C).
RhoA pathways regulate blebbing
The inhibitory effect of Rho-kinase inhibitors on blebbing sug-
gested a role for the small GTPase RhoA. Immunostaining for 
active RhoA after TCA fi  xation (Kamijo et al., 2006; this pre-
serves both expanding and retracting blebs; unpublished data) 
and expression of GFP-tagged RhoA revealed the presence of 
RhoA colocalized with the bleb membrane during all stages of 
blebbing (Fig. 10 A).
We investigated the effect of direct RhoA inhibition using 
proteins that affect RhoA activity. Microinjection of Rho gua-
nine nucleotide dissociation inhibitor α (GDIα), the catalytic 
domain of p50Rho GTPase activating protein (GAP), the 
RhoGTPase-binding domain of rhotekin, or C3 exoenzyme lead 
to a signifi  cant decrease in the proportion of blebbing cells 
compared with controls (Table II). Unfortunately, in all cases, 
RhoA inhibition was too slow to assess its effect on actin nucle-
ation or bleb retraction. Consistent with the microinjection re-
sults, overexpression of GFP-tagged RhoGDIα, rhotekin-binding 
domain, or p50RhoGAP lead to a signifi  cant decrease in the 
proportion of blebbing cells (Table III). 
Localization of active RhoA at the cell membrane and the 
presence of ezrin within blebs directed our attention to Rho 
guanine nucleotide exchange factors (GEFs) reported to as-
sociate with ezrin, dbl and Net1 (Tran Quang et al., 2000; Vanni 
et al., 2004). GFP-tagged Net1 localized to the nucleus of 
  blebbing cells (not depicted), but GFP-tagged KIAA0861, a 
GEF closely related to dbl (Rossman et al., 2005), colocalized 
Figure 9.  Myosin II powers bleb retraction 
cytochalasin D, an actin depolymerizer, was 
added at time t = −2 min and treatment was 
pursued until t  = 0 min.  Cytochalasin was 
washed out and, in some cases, blebbistatin 
was included in the washout medium. This sec-
ond treatment was pursued for 15–50 min, 
and then a ﬁ  nal washout or inactivation was 
effected. All images were acquired using con-
focal microscopy. The timing of each image in 
minutes is indicated in white text. (A) Blebs that 
emerged after the onset of treatment formed 
actin puncta (red), recruited MRLC (green) to 
puncta, and retracted upon washout (white 
  arrow). (B) Inclusion of the myosin ATPase inhibi-
tor blebbistatin in the washout medium did not 
prevent the formation of an actin rim but 
stopped retraction (white arrow). Upon bleb-
bistatin inactivation (t = 50 min), retraction 
proceeded normally. (C) Inclusion of blebbista-
tin in the washout medium did not inhibit my-
osin recruitment to the bleb rim (white arrow). 
Upon blebbistatin inactivation (t = 27 min), 
  retraction proceeded normally. Bars, 5 μm.
Table II. Effect of microinjected reagents on proportion of blebbing cells
Protein Target protein Concentration in the 
micropipette
Number of cells 
microinjected
Percentage of cells blebbing 
after microinjection
P value
Control (3kDa dextran) 100 μg/ml
−1 79 54
Neomycin sulfate PIP2 10 mM 14 57 0.8
FERM domain of ezrin ERM proteins 600 μg/ml
−1 25 60 0.5
Ezrin T567D ERM proteins 1.5 mg/ml
−1 21 5 <0.01
p50RhoGAP Rho-GTPases 600 μg/ml
−1 15 33 <0.01
Rhotekin binding domain RhoA 600 μg/ml
−1 40 35 <0.01
RhoGDIα RhoA 1.2 mg/ml
−1 28 32 <0.01
C3-exoenzyme Rho 100 μg/ml
−1 39 13 <0.01JCB • VOLUME 175 • NUMBER 3 • 2006  486
with the cell membrane throughout all phases of blebbing 
(Fig. 10 B).
In summary, RhoA was present at the membrane during 
all phases of blebbing, microinjection, or overexpression of re-
combinant proteins that inactivated RhoA-inhibited blebbing, 
and KIAA0861, which is a RhoGEF closely related to dbl, was 
present at the membrane during all phases of blebbing. These 
data suggest that signaling downstream of RhoA is essential for 
blebbing; however, inhibition of Rho-GTPase activity was too 
slow to distinguish the role of RhoA in actin nucleation versus 
bleb retraction.
Discussion
Blebbing offers a window into the sequence of events leading to 
the reassembly of a contractile cortical actin cytoskeleton. One 
limitation of our study is that the accumulation of small quanti-
ties of proteins at the bleb cortex may be obscured by back-
ground fl  uorescence emanating from cytosolic protein. Indeed, 
we estimate that proteins must be  10% more concentrated at 
the cortex than in the cytosol for us to reliably image localization 
(unpublished data). We show that bleb retraction is the result 
of the sequential assembly of actin–membrane linker proteins, 
actin, actin-bundling proteins, regulatory proteins, and fi  nally 
motor proteins.
Two proteins of the erythroid submembranous cytoskele-
ton, protein 4.1 and ankyrin B, were present at the membrane 
during all phases of blebbing, and both spectrin and adducin 
were present in retracting blebs. This suggested that an erythroid-
like submembranous cytoskeleton may protect the cell mem-
brane from lysis during the repeated cycles of bleb expansion 
and retraction. Nonerythroid cells have a spectrin-based net-
work that extends over the entire cell surface; however, its func-
tion is unclear because microinjection of antibodies to spectrin 
that precipitated the network had no deleterious consequences 
in cells (Mangeat and Burridge, 1984). This may be because, 
under normal circumstances, the cell membrane is tethered to 
the actin cortex by ERM proteins independently from its attach-
ment to the spectrin meshwork.
Ezrin played an important role in the stabilization of 
  actin–membrane attachment in retracting blebs. Microinjection of 
the FERM domain of ezrin, which inhibits attachment of cellu-
lar ezrin to actin, weakened the actin–membrane attachment 
causing transient detachment of the actin cortex from the mem-
brane during bleb retraction. Conversely, microinjection of a 
dominant active ezrin caused cessation of blebbing. These ef-
fects suggest that ezrin contributes strongly to actin–membrane 
adhesion energy. Decreasing the adhesion energy by impeding 
actin–membrane attachment increases bleb nucleation, whereas 
increasing the adhesion energy decreases bleb nucleation. 
Hence, two independent systems may coexist to protect the 
membrane from lysis. One, an erythroid-like submembranous 
cytoskeleton, is present during all phases of blebbing; the other 
tethers the membrane to the actin cytoskeleton via ERM pro-
teins, is reassembled shortly after expansion ceases, and is regu-
lated by an unknown staurosporine-sensitive kinase.
The actin cortex in newly formed blebs assembles into a 
cagelike structure cross-linked by actin-bundling proteins. The 
mechanism of actin nucleation beneath the membrane of newly 
formed bleb remains unclear, as neither Arp2/3 nor mDia1 lo-
calize to the bleb membrane. The role of RhoA in blebbing reg-
ulation suggests a role for a different formin in actin nucleation. 
The new actin cortex confers resistance to further expansion, as 
well as an essential framework for the transduction of forces 
generated by myosin-based movement. The cortical shell con-
sisted of long criss-crossing strands of actin that intersected at 
 200-nm intervals, was 3–4 fi  laments thick, and was devoid of 
internal structures. Blebs from mitotic HeLa cells and the cortex 
of cells rounded in metaphase also had similar, but tighter, ultra-
structures. Actin-bundling proteins rigidify actin gels by reduc-
ing their degrees of freedom. In blebs, actin-bundling proteins 
appeared later than actin, colocalized with the gel and presum-
ably coassembled with it. Some actin-bundling proteins local-
ized to the bleb rim shortly after actin (α-actinin and coronin), 
and signifi   cantly earlier than others (fi  mbrin). This  may  be 
caused by a difference in cross-linking distance (α-actinin, 
Figure 10.  Localization of RhoGTPase RhoA 
and the RhoGEF KIAA0861 during blebbing. 
Timing relative to the ﬁ  rst image is indicated in 
white text. All images were acquired using 
confocal microscopy. In all images, actin is 
shown in green and the protein of interest in 
red. Both RhoA (A) and the RhoGEF KIAA0861 
(B) localized to the bleb membrane during all 
phases of blebbing. In both cases, the proteins 
were displaced toward the cell exterior when 
compared with actin. Bars, 2 μm.
Table III. Effect of protein expression on proportion of blebbing cells
Protein Percentage cells 
blebbing
Number of cells P value
GFP (Control) 58 98
Rhotekin-binding 
domain
5 64 <0.01
RhoGDIα 5 70 <0.01
p50 RhoGap 0 37 <0.01CORTEX ASSEMBLY IN BLEBS • CHARRAS ET AL. 487
40 nm vs. fi  mbrin, 14 nm) that enables the longer ones to par-
ticipate in early network assembly through a more effi  cient cap-
ture of surrounding actin fi  laments. As expected, the recruitment 
of α-actinin was dependent on the presence of an actin gel, but, 
surprisingly, the recruitment of coronin 3 was not, consistent 
with the hypothesis that it may play a role in reinforcing links 
between the actin cortex and the membrane (Spoerl et al., 2002). 
The fi  nal step was the assembly of the contractility control ap-
paratus and the recruitment of motor proteins. Tropomyosin and 
tropomodulin, two proteins involved in the control of myosin 
contractility, are recruited to the bleb rim. Finally, myosin II lo-
calizes to discrete foci, which may correspond to minifi  laments 
or ribbons of myosin (similar to the organization observed in 
  lamellipodium; Verkhovsky et al., 1995) and these provide the 
force needed for retraction.
A central question in bleb dynamics is how cortex reas-
sembly is triggered. We envisage two possibilities. First, cortex 
assembly is constitutive, but slow relative to bleb expansion. 
In this model, the expanding bleb is cortex free because of its 
rapid growth in area. When expansion slows, constitutive cor-
tex assembly simply catches up. Cortex assembly may require 
a signaling pathway, but no special detection mechanisms to 
differentiate bleb membrane from generic membrane. The pres-
ence of both RhoA and a RhoGEF at the cell membrane at all 
stages of blebbing supports this model. In addition, ezrin may 
be recruited to the membrane via direct attachment to the Rho-
GEF (Vanni et al., 2004). In the second model, cortex assembly 
is triggered by an active signaling process downstream of some 
sensor that detects a change in the bleb membrane, such as 
membrane tension or exposed lipid head groups. In this model, 
cortex reassembly is locally triggered by a special property of 
the bleb membrane. For example, as the membrane tears from 
the actin cortex, PIP2 gets freed from its interaction partners, 
and this may provide an upstream signal for cortex reassembly. 
Another possibility is that the tension change concomitant with 
bleb expansion (Dai and Sheetz, 1999) could be detected by 
tension-sensitive mechanisms. Our data do not support either 
of these possibilities because treatment with chelators of PIP2 
(neomycin sulfate and PBP10) or blockers of mechanosensi-
tive channels (gadolinium chloride and GsMTx-4; unpublished 
data) had no effect on bleb retraction. Though, at present, our 
data seem to favor the constitutive assembly model, we can-
not provide defi  nitive evidence and more in-depth studies will 
be necessary.
Finally, Do our observations provide any clues as to the 
function of blebbing? Most animal cells bleb during cytokinesis 
and apoptosis, and some bleb during cell migration. Blebbing 
might simply be an epiphenomenon caused by strong activation 
of cortical contractility, or it might have a real function in these 
processes. Our observations reveal that blebbing effi  ciently trig-
gers assembly of new cortex that can integrate into the bulk cor-
tex as the bleb contracts. It might, thus, function as a pathway 
for new cortex generation when cells need to rapidly expand 
their cortical surface area, such as during cytokinesis. Consis-
tent with this hypothesis, inhibition of actin polymerization at 
the poles of dividing cells inhibits cytokinesis more effi  ciently 
than inhibition at the furrow (Guha et al., 2005). As blebbing 
normally occurs at the poles during cytokinesis, it may be an ef-
fi  cient way of generating new cortex to increase cortical surface 
area while maintaining the furrow stable.
Materials and methods
Cell culture
Filamin-deﬁ  cient M2 cells (Cunningham et al., 1992) were cultured in MEM 
with Earle’s salts (Invitrogen) with penicillin/streptomycin, 10 mM Hepes, 
and 10% 80:20 mix of donor calf serum/fetal calf serum. All   imaging was 
done in Leibovitz L-15 media (Invitrogen) supplemented with 10% 80:20 
mix of donor calf serum/fetal calf serum. HeLa cells were cultured in DME 
(Invitrogen) with penicillin/streptomycin and 10% fetal calf serum.
Plasmid construction, mutagenesis, transfection, and recombinant 
protein puriﬁ  cation
Detailed information about all of the plasmids used in this study is summa-
rized in Table S1 (available at http://www.jcb.org/cgi/content/full/
jcb.200602085/DC1). Unless otherwise noted, the full length of each 
gene was cloned.
Xenopus laevis MRLC and MHC tagged with GFP were gifts from A. 
Straight (Stanford University, Stanford, CA). Anillin-GFP was a gift from 
Field. mRFP and TDRFP were gifts from R. Tsien (University of California, 
San Diego, La Jolla, CA). The membrane was visualized by transfecting 
the cells with the PH domain of PLCδ tagged with GFP (a gift from T. Balla, 
National Institutes of Health, Bethesda, MD) or mRFP. Ankyrin B-GFP was 
a gift from V. Bennett (Duke University, Durham, NC). Moesin-GFP was a 
gift from H. Furthmayr (Stanford University). Myr2 and myr3-GFP were 
gifts from T. Lechler (Duke University). X. laevis tropomyosin 4-GFP, tropo-
modulin 3-GFP, and mDia1-GFP were gifts from N. Watanabe (University 
of Kyoto, Kyoto, Japan). Arp3-GFP and capping protein-GFP were gifts 
from D. Schafer (University of Virginia, Charlottesville, VA). Fascin-GFP 
was a gift from P. McCrea (University of Texas, Houston, TX). Sept6-GFP 
was a gift from M. Kinoshita (University of Kyoto). Vimentin-GFP was a 
kind gift from R. Goldman (Northwestern University, Chicago, IL). 6xHis-
FERM domain of ezrin-mRFP was a gift from V. Gerke (University of Muen-
ster, Muenster, Germany). Rhotekin-binding domain-GFP was a gift from 
W. Bement (University of Wisconsin, Madison, WI). 6xHis-Rhotekin bind-
ing domain-mRFP was a gift from R. Grosse (University of Heidelberg, Hei-
delberg, Germany). GST-tagged RhoA, RhoGDIGα, and p50RhoGAP 
were gifts from A. Hall (Memorial Sloan-Kettering Cancer Center, New 
York, NY). Actin-GFP and tubulin-GFP were purchased from CLONTECH 
Laboratories, Inc.
Ezrin (NM003379), coronin 3 (NM014325), annexin II 
(NM1002858), and ﬁ  mbrin (NM005032) cDNA were obtained by RT-
PCR from total mRNA extracts from M2 cells. Human Protein 4.1 (nonery-
throid isoform, BC039079), human α-actinin (NM001102), human VASP 
(BC015289), human Net1 (BC053553), human KIAA0861 (BC064632), 
and human adducin (BC013393) cDNA were obtained from Opens Bio-
systems. The FERM domain of ezrin was obtained by RT-PCR of ezrin amino 
acids 0–309.
The full-length PCR products of ezrin, FERM domain, coronin, and 
  protein 4.1 were directly ligated into pcDNA3.1-topo-GFP-CT (Invitrogen). 
Full-length  α-actinin, adducin, annexin II, p50RhoGAP, RhoGDIα, RhoA, 
KIAA0861, Net1, and ﬁ  mbrin PCR products were ligated into zero blunt vec-
tors (Invitrogen), ampliﬁ  ed, cut with the appropriate restriction enzymes, and 
ligated into GFP-C1, GFP-C3, or GFP-N1 (CLONTECH   Laboratories, Inc.).
Actin localization was visualized by transfecting cells with an ade-
novirus containing GFP-tagged human β-actin (Charras et al., 2005). Alter-
natively, we used a melanoma cell line stably expressing actin-mRFP 
derived from wild-type M2 cells infected with actin-mRFP retrovirus in the 
retroviral vector pLNCX2 (CLONTECH Laboratories, Inc.).
For simultaneous examination of GFP-tagged actin and other pro-
teins of interest (MRLC, MHC, tropomyosin, ﬁ  mbrin, ezrin, PH-PLCδ, FERM, 
and α-actinin), we created mRFP variants of all of the aforementioned GFP-
tagged protein constructs, except coronin, which was examined in con-
junction with actin-mRFP.
Ezrin point mutations T567A (impaired actin binding and head-to-
tail association) and T567D (constitutively active actin binding and im-
paired head-to-tail association; Gautreau et al., 2000) were performed 
using the one-step mutagenesis kit (Stratagene) on wild-type ezrin in 
pcDNA3.1-topo-GFP-CT. 6xHis-tagged ezrin T567D GFP was created by 
directly ligating the full-length PCR product of ezrin T567D GFP into 
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All gene products were veriﬁ  ed by sequencing. Plasmid transfec-
tions were effected using Lipofectamine Plus (Invitrogen) according to the 
manufacturer’s protocol, using 1 μg of cDNA per well of a 6-well plate 
  (Invitrogen) and cells were examined the day after. In all cases tested, our 
GFP-tagged constructs of actin-binding proteins showed similar localiza-
tion to immunoﬂ  uorescence of endogenous protein (13 tested) or to local-
izations reported in the literature (9 proteins), and none of them perturbed 
blebbing signiﬁ  cantly.
Recombinant protein expression and puriﬁ  cation were effected 
  using standard methods for His-tagged or GST-tagged protein puriﬁ  cation. 
The puriﬁ  ed proteins were either eluted directly or dialyzed overnight in ei-
ther microinjection buffer (50 mM K-glutamate and 0.5 mM MgCl2, pH 
7.0) or in 50 mM KCl and 20 mM Tris-HCl, pH 7.0.
Western-blotting
For Western blotting, cells were scraped off the tissue culture dish in 
PBS, pelleted, resuspended in an equal volume of Laemmli buffer with 
β-  mercaptoethanol, and boiled for 15 min. The samples were then loaded 
onto SDS-PAGE gels. Standard Western blotting techniques were used. 
  Antibodies used (all monoclonal) were as follows: ﬁ  lamin A (1:1,000; 
CHEMICON International, Inc.), ezrin (1:2,000; Sigma-Aldrich), GFP 
(1:2,000; CLONTECH Laboratories, Inc.). HeLa cells were used as a posi-
tive control for ﬁ  lamin expression.
Immunostaining
For all antibodies except RhoA, the cells were ﬁ  xed for 1 min at room tem-
perature in a solution containing ﬁ  xation buffer (137 mM NaCl, 5 mM 
KCl, 1.1 mM NaH2PO4, 0.4 mM KH2PO4, 2 mM MgCl2, 2 mM K-EGTA, 
5 mM Pipes, pH 6.8, and 5.5 mM Glucose) with 0.1% glutaraldehyde, 1% 
formaldehyde, and 0.3% Triton X-100. The cells were then ﬁ  xed for 10 min 
further at room temperature in ﬁ  xation buffer with 0.5% glutaraldehyde. 
For active RhoA staining, the cells were ﬁ  xed with 10% TCA for 15 min on 
ice and treated as above. Monoclonal anti-RhoA antibody was purchased 
from Santa Cruz Biotechnologies, Inc. and used at 1:100 dilution. Cells 
were then stained using standard immunostaining techniques (Charras and 
Horton, 2002). Rhodamine-labeled phalloidin, monoclonal anti–α-actinin, 
polyclonal anti-vimentin, monoclonal anti-ezrin, monoclonal anti-MRLC, 
monoclonal anti-tropomyosin, and monoclonal anti-tubulin were purchased 
from Sigma-Aldrich and used at a 1:200, 1:200, 1:40, 1:100, 1:100, 
1:100, and 1:500 dilutions, respectively. Polyclonal anti-spectrin, T-Plastin 
(ﬁ  mbrin), and adducin antibodies were purchased from Santa Cruz Bio-
technologies, Inc., and they were all used at 1:100 dilution. Polyclonal 
anti-myosin antibody was purchased from Biomedical Technologies and 
used at a 1:400 dilution. Monoclonal anti-anillin, polyclonal Arp3, and 
polyclonal VASP antibodies were gifts from C. Field (Harvard Medical 
School, Boston, MA), C. Egile (Harvard Medical School), and F. Southwick 
(University of Florida, Gainesville, FL), respectively, and they were used 
at 1:500, 1:500, and 1:100 dilutions. Monoclonal anti-fascin was from 
  DakoCytomation and used at 1:100 dilution.
Confocal microscopy
All ﬂ  uorescent imaging was done using a 1.3 NA 100× oil-immersion ob-
jective on an inverted microscope (Nikon TE-2000; Nikon) interfaced to a 
spinning disk confocal microscope (Perkin-Elmer) equipped with a heating 
stage heated to 37°C. Images were captured on a charge-coupled device 
camera (Orca ER; Hamamatsu) and acquired on a PC using Metamorph 
software (Molecular Devices). Images were acquired either 488-nm wave-
length for GFP-tagged proteins and FITC-labeled secondary antibodies or 
with 568-nm wavelength for RFP-tagged proteins and TRITC-labeled sec-
ondary antibodies. For display, images were low pass ﬁ  ltered and scaled 
such that background ﬂ  uorescence was minimal.
Measurement of appearance time for proteins
To assess the time of recruitment to the bleb rim of different proteins in rela-
tionship to actin, we cotransfected cells with actin-GFP or -mRFP and one of 
MRLC-TDRFP, α-actinin-mRFP, ﬁ  mbrin-mRFP, tropomyosin-mRFP, coronin-GFP, 
or ezrin-mRFP. The next day, cells were imaged for 120 s at 1-s intervals. 
The intensity of both reporter constructs in retracting blebs was evaluated 
along a line drawn through the diameter using Metamorph (Molecular De-
vices). When one of the proteins appeared at the bleb rim, a clear peak in 
intensity above background could be observed. Actin was taken as the 
time reference and we measured the time of apparition of a ﬂ  uorescence 
intensity peak at the bleb rim for each protein in comparison to actin. We 
collected peak appearance times for a maximum of 5 blebs per cell, for a 
minimum of 5 different cells for each protein, and a minimum of 17 blebs. 
For each protein, the time it appeared was compared with actin using a 
t test. Proteins were compared pairwise with a t test. Tests were considered 
signiﬁ  cant if P < 0.01.
Drug treatments for assessment of dependence relationships
To assess whether F-actin was required for the recruitment of proteins in-
volved in bleb retraction, we transfected cells with the protein of interest 
tagged with GFP and treated the cells with cytochalasin D (Sigma-Aldrich), 
a small molecule that promotes actin depolymerization by capping the fast-
growing end of F-actin ﬁ  laments. In all cases, the cells were ﬁ  rst imaged for 
20 time points at 5-s intervals to ascertain that the protein of interest local-
ized normally. 5 μM cytochalasin D was added and the cells were imaged 
for an additional 100 time points.
To assess the dependence of actin recruitment on the presence of 
  ezrin, we treated cells stably expressing actin-mRFP and transfected with 
  ezrin-GFP with inhibitors to known regulators of ezrin, following a protocol 
identical to the one used with cytochalasin D. For ease of visualization, ac-
tin is shown in green in the ﬁ  gures and ezrin in red. The inhibitors used 
were Y27632 (25 μM; Calbiochem), H89 (20 μM; Calbiochem), K252C 
(50  μM; Calbiochem), HA1077 (20 μM; Sigma-Aldrich), Gö6976 
(15 μM; Calbiochem), H9 (50 μM; Tocris), Genistein (100 μM; Calbiochem), 
pertussis toxin (1 μg/ml
−1), suramin (300 μM; Calbiochem), PBP-10 
(10 μM; Calbiochem), and staurosporine (5 μM; Calbiochem).
To investigate the proteins and signaling events important for actin 
nucleation and bleb retraction, we transiently treated M2 cells transfected 
with actin-GFP and MRLC-TDRFP with 2.5 μM cytochalasin D for 2 min. 
This created a population of blebs devoid of actin that could reform an ac-
tin rim and recruit myosin once cytochalasin was removed. To remove cyto-
chalasin, we exchanged medium 4 times. In experiments to determine how 
blebs retracted, we included blebbistatin (100 μM; Tocris) in the washout 
medium and treated for 10–50 min, then inactivated blebbistatin by expo-
sure to 488-nm light for 600 ms (Sakamoto et al., 2005). During the whole 
procedure, images were acquired at 488 nm (except during blebbistatin 
treatment) and 568 nm every 10 s.
SEM of the cytoskeleton
For SEM imaging, cells were processed as described in Svitkina and Borisy 
(1998) with minor modiﬁ  cations. 2 h before treatment, cells were plated 
onto 12-mm glass coverslips. 10 min before, blebbing was stimulated by 
addition of fresh medium (Leibowitz L15 medium with 10% 80:20 DCS/
FCS). The coverslips were washed 3 times with L15 without serum and 
transferred to extraction buffer for 20 min (50 mM imidazole, 50 mM KCl, 
0.5 mM MgCl2, 0.1 mM EDTA, 1 mM EGTA, 1% CHAPS, 2% Triton X-100, 
2% PEG 35000, 10 μM phalloidin, and 1 μl/ml
−1 RNase cocktail (RNase 
T1 and A; Ambion), pH 6.8). For myosin S1 decoration of the actin ﬁ  la-
ments, the cells were incubated with 1 mg/ml
−1 myosin S1 (Sigma-Aldrich) 
in cytoskeleton buffer (50 mM Imidazole, 50 mM KCl, 0.5 mM MgCl2, 
0.1 mM EDTA, and 1 mM EGTA, pH 6.8) for 30 min. The remainder of the 
protocol was identical to Svitkina and Borisy (1998). The cells were then 
dehydrated by exposure to serial ethanol dilutions, dried in an autosamdri-
815 (Tousimis) critical point dryer, coated with 5–6 nm platinum-palladium 
and imaged using the in-lens detector of a SEM (Leo 892; Carl Zeiss 
  MicroImaging, Inc.). For surface examination, cells were ﬁ  xed for 10 min 
in 3% glutaraldehyde in cacodylate buffer, followed by a post-ﬁ  x in tannic 
acid and uranyl-acetate. The sample was then prepared as above.
Thin sectioning TEM
For TEM examination, the cells were ﬁ  rst permeabilized with 0.025% sa-
ponin in the same ﬁ  xation buffer used for immunostaining for 1 min to re-
lease cytosol. They were ﬁ  xed in ﬁ  xation buffer with 1.5% glutaraldehyde 
and 50 mM lysine in 50 mM cacodylate, pH 7.0, for 6 min and post-ﬁ  xed 
in 3% glutaraldehyde in cacodylate buffer for 6 min. For labeling experi-
ments, the cells were then incubated with phalloidin-XX biotin (Invitrogen) 
for 30 min, followed by incubation with streptavidin–gold beads (EY 
  laboratories). The remainder of the procedure was performed as described 
in Brieher et al. (2004).
Microinjection
Cells were plated onto glass coverslips the day before microinjection. Two 
cell populations were used for microinjection; wild-type M2 cells trans-
fected with GFP-actin or M2 cells stably expressing actin-mRFP.
Microinjections were performed using standard procedures. In brief, 
borosilicate glass needles were pulled using a Sutter P-89. Before micro-
injection, the protein solution was centrifuged at top speed in a tabletop 
centrifuge to remove aggregates. Cells were microinjected with an Eppen-
dorf 5242 microinjector (Eppendorf AG) using 30 hPa backpressure. CORTEX ASSEMBLY IN BLEBS • CHARRAS ET AL. 489
For proteins that were not ﬂ  uorescently tagged, 100 μg/ml
−1 3-kD dextran-
FITC (Invitrogen) was added to the protein solution. Recombinant C3-
  exoenzyme was a gift from K. Burridge (University of North Carolina, 
Chapel Hill, NC).
After microinjection, the cells were left to recuperate for at least 10 
min. Cells that had been properly microinjected were identiﬁ  ed by their ﬂ  u-
orescence. Time-lapse videos of the cells were acquired over a period of 
10 min–1 h after microinjection, using either a 40× objective for whole 
population studies or a 100× objective for localization studies. Time-lapse 
microscopy was performed on an inverted ﬂ  uorescence  microscope 
(TE300; Nikon) with a ﬁ  lter wheel. Images were acquired on a charge-
coupled device camera and transferred to a PC computer using Meta-
morph software.
The proportion of blebbing cells within a microinjected population 
was evaluated by manually counting the total number of cells and the 
  number of blebbing cells. The proportion of microinjected cells blebbing 
was compared with the proportion of cells blebbing after microinjection 
with 3-kD dextran-FITC, using a χ-square test with Yates correction.
Evaluation of the proportion of blebbing cells during transient 
protein expression
Cells were transiently transfected with GFP (control), p50RhoGAP-GFP, 
Rhotekin binding domain-GFP, or RhoGDIα-GFP. The proportion of bleb-
bing cells within a transfected population was evaluated by manually 
counting the total number of transfected cells and the number of transfected 
blebbing cells. The effect of protein expression was evaluated by compar-
ing the proportion of blebbing cells expressing the protein of interest to the 
proportion of blebbing cells expressing GFP only, using a χ-square test with 
Yates correction.
Online supplemental material
Fig. S1 shows protein localization in ﬁ  xed blebbing cells using immuno-
ﬂ  uorescence. Fig. S2 shows that ezrin stabilizes cell shape. Fig. S3 shows 
localization of GFP-tagged ezrin mutants in spreading cells at different times 
after plating. Detailed information about all of the plasmids used in this 
study is summarized in Table S1. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200602085/DC1.
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